blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1946122

EP1946122 - SINGLE RECEPTOR ASSAYS FOR IMMUNOSUPPRESSIVE DRUGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.12.2012
Database last updated on 13.11.2024
Most recent event   Tooltip14.12.2012Application deemed to be withdrawnpublished on 16.01.2013  [2013/03]
Applicant(s)For:DE 
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO  SE  SI  SK  TR 
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2008/30]For:DE 
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HU  IE  IS  IT  LI  LT  LU  LV  MC  NL  PL  PT  RO  SE  SI  SK  TR 
F.HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / SIGLER, Gerald
888 Ironwood Drive
Carmel, IN 46033 / US
02 / GHOSHAL, Mitali
10153 Parkshore Drive
Noblesville, IN 46060 / US
03 / DORN, Allan
14241 Dove Drive
Carmel, IN 46033 / US
04 / RASHID, Shaker
10391 Bicknell Circle
Fishers, IN 46038 / US
 [2008/30]
Application number, filing date06791854.006.09.2006
[2008/30]
WO2006EP08664
Priority number, dateUS20050714712P07.09.2005         Original published format: US 714712 P
[2008/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007028580
Date:15.03.2007
Language:EN
[2007/11]
Type: A2 Application without search report 
No.:EP1946122
Date:23.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.03.2007 takes the place of the publication of the European patent application.
[2008/30]
Search report(s)International search report - published on:EP10.05.2007
ClassificationIPC:G01N33/94, C12Q1/533
[2008/30]
CPC:
G01N33/9493 (EP,US); G01N21/6445 (EP,US); G01N33/5308 (EP,US);
G01N33/54346 (EP,US); G01N2021/6432 (EP,US); G01N21/76 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/30]
TitleGerman:EIN-REZEPTOR-TESTS FÜR IMMUNSUPPRESSIVA[2008/30]
English:SINGLE RECEPTOR ASSAYS FOR IMMUNOSUPPRESSIVE DRUGS[2008/30]
French:DOSAGES À RÉCEPTEUR UNIQUE POUR MÉDICAMENTS IMMUNODÉPRESSEURS[2008/30]
Entry into regional phase07.04.2008National basic fee paid 
07.04.2008Designation fee(s) paid 
07.04.2008Examination fee paid 
Examination procedure19.06.2007Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.04.2008Examination requested  [2008/30]
21.05.2008Amendment by applicant (claims and/or description)
11.03.2009Despatch of a communication from the examining division (Time limit: M06)
16.09.2009Reply to a communication from the examining division
18.03.2010Despatch of a communication from the examining division (Time limit: M06)
28.09.2010Reply to a communication from the examining division
16.03.2012Despatch of a communication from the examining division (Time limit: M04)
30.08.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/03]
11.09.2012Application deemed to be withdrawn, date of legal effect  [2013/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.03.2009
Fees paidRenewal fee
05.09.2008Renewal fee patent year 03
04.09.2009Renewal fee patent year 04
07.09.2010Renewal fee patent year 05
08.09.2011Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.201207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]US5322772  (SOLDIN STEVEN J [US]) [X] 1,5,6,8,9,14,16,19,23,25 * page 3, lines 4-23 * * page 11, line 6 * * page 11, line 21 - page 12, line 1 * * page 16, lines 13-24 * * page 6, lines 6-25 * * claims 11-14 * [Y] 1-10,13-20,23-26;
 [Y]EP1239285  (ROCHE DIAGNOSTICS GMBH [DE], et al) [Y] 2-4,7,15,17,18,26 * the whole document *;
 [XY]EP0372862  (CHILDREN S NATIONAL MEDICAL CE [US]) [X] 1,5,6,8,14,16,25 * the whole document * [Y] 2-4,7,13,17,18,24;
 [XY]WO9117439  (CHILDRENS RES INST [US]) [X] 1,5,6,8,11,14,16,21,25 * the whole document * [Y] 2-4,7,12,13,17,18,22,24;
 [PY]US2005208607  (ROBERTS MARK [US], et al) [PY] 1-9,13,14,16-19,23-25 * paragraphs [0008] , [0009] , [0047] - [0089] - [0108] - [0149] *
 [DY]  - LIANG J ET AL, "Structure of the human 25 kDa FK506 binding protein complexed with rapamycin", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 1996 UNITED STATES, (1996), vol. 118, no. 5, ISSN 0002-7863, pages 1231 - 1232, XP002405244 [DY] 10,20 * page 1231, column 1 *

DOI:   http://dx.doi.org/10.1021/ja953139w
 [Y]  - SITTAMPALAM G S ET AL, "HIGH-THROUGHPUT SCREENING: ADVANCES IN ASSAY TECHNOLOGIES", CURRENT OPINION IN CHEMICAL BIOLOGY, CURRENT BIOLOGY LTD, LONDON, GB, (1997), vol. 1, ISSN 1367-5931, pages 384 - 391, XP002940175 [Y] 13,24 * abstract *

DOI:   http://dx.doi.org/10.1016/S1367-5931(97)80078-6
 [DY]  - DAVIS ET AL, "An immunophilin-binding assay for sirolimus.", CLINICAL THERAPEUTICS. 2000, (2000), vol. 22 Suppl B, ISSN 0149-2918, pages B62 - B70, XP002405243 [DY] 12,22 * page B66, column 1, lines 11-17 - column 2, lines 1-6; table 2 * * page B67, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0149-2918(00)89023-2
 [DY]  - DECENZO M T ET AL, "FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.", PROTEIN ENGINEERING. FEB 1996, (199602), vol. 9, no. 2, ISSN 0269-2139, pages 173 - 180, XP002061407 [DY] 12,22 * table 2 * * abstract *
 [Y]  - ARMSTRONG V W ET AL, "Drug monitoring of sirolimus and everolimus", LABORATORIUMSMEDIZIN 2003 GERMANY, (2003), vol. 27, no. 5-6, ISSN 0342-3026, pages 222 - 227, XP002420543 [Y] 1,5,6,8,9,13,14,16,19,23-25 * page 223, column 1, paragraph 1 - column 2, paragraph 1; figure 1 * * page 225, column 1, paragraph 3 - page 226, column 2, paragraph 3 * * abstract *

DOI:   http://dx.doi.org/10.1515/LabMed.2003.034
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.